HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kyu Joong Ahn Selected Research

Seborrheic Dermatitis

10/2017Preliminary study of histamine H4 receptor expressed on human CD4+ T cells and its immunomodulatory potency in the IL-17 pathway of psoriasis.
6/2017In Vitro Anti-Malassezia Activity of Castanea crenata Shell and Oil-Soluble Glycyrrhiza Extracts.
12/2016Efficacy and Safety of Cream Containing Climbazole/Piroctone Olamine for Facial Seborrheic Dermatitis: A Single-Center, Open-Label Split-Face Clinical Study.
5/2016Isolation and identification of Malassezia species from Chinese and Korean patients with seborrheic dermatitis and in vitro studies on their bioactivity on sebaceous lipids and IL-8 production.
12/2014Clinical Evaluation of a New-Formula Shampoo for Scalp Seborrheic Dermatitis Containing Extract of Rosa centifolia Petals and Epigallocatechin Gallate: A Randomized, Double-Blind, Controlled Study.
5/2010Epidemiologic Study of Malassezia Yeasts in Seborrheic Dermatitis Patients by the Analysis of 26S rDNA PCR-RFLP.
3/2009Clinical efficacies of topical agents for the treatment of seborrheic dermatitis of the scalp: a comparative study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kyu Joong Ahn Research Topics

Disease

7Seborrheic Dermatitis
10/2017 - 03/2009
7Neoplasms (Cancer)
01/2017 - 03/2014
6Psoriasis (Pustulosis Palmaris et Plantaris)
01/2021 - 01/2014
4Atopic Dermatitis (Atopic Eczema)
08/2019 - 02/2010
4Erythema
01/2019 - 12/2014
3Skin Diseases (Skin Disease)
08/2019 - 08/2009
2Pruritus (Itching)
08/2019 - 08/2009
2Pain (Aches)
06/2018 - 01/2017
2Alopecia (Baldness)
06/2016 - 09/2014
2Inflammation (Inflammations)
09/2014 - 05/2011
2Acne Vulgaris
11/2013 - 08/2011
1Rosacea (Acne Rosacea)
01/2019
1Dandruff
06/2017
1Drug Hypersensitivity Syndrome
04/2017
1Psychotic Disorders (Schizoaffective Disorder)
04/2017
1Drug Eruptions (Drug Eruption)
04/2017
1Eosinophilia
04/2017
1Eczema
12/2016
1Xeroderma Pigmentosum (Kaposi's Disease)
12/2016
1Ovarian Neoplasms (Ovarian Cancer)
11/2016
1Atherosclerosis
10/2015
1Hypersensitivity (Allergy)
07/2015
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2014
1Carcinoma (Carcinomatosis)
09/2014
1Melanoma (Melanoma, Malignant)
07/2014
1Hyperpigmentation
07/2014
1Cicatrix (Scar)
11/2013
1Tinea Versicolor (Pityriasis Versicolor)
11/2012

Drug/Important Bio-Agent (IBA)

4Ribosomal DNA (rDNA)IBA
08/2011 - 02/2010
3CytokinesIBA
12/2019 - 01/2014
3Interleukin-17 (Interleukin 17)IBA
12/2019 - 12/2015
2Adrenal Cortex Hormones (Corticosteroids)IBA
08/2019 - 04/2017
2Histamine Receptors (Histamine Receptor)IBA
08/2019 - 10/2017
2SteroidsIBA
08/2019 - 03/2009
2Melanins (Melanin)IBA
01/2019 - 03/2016
2Proteins (Proteins, Gene)FDA Link
11/2016 - 09/2014
2Biological ProductsIBA
11/2016 - 05/2010
2Interleukin-23 (Interleukin 23)IBA
12/2015 - 01/2014
2Interleukin-2 (IL2)IBA
12/2015 - 01/2014
2pyrithione zinc (ZPT)FDA Link
12/2014 - 03/2009
2Reactive Oxygen Species (Oxygen Radicals)IBA
09/2014 - 07/2014
2MicroRNAs (MicroRNA)IBA
09/2014 - 03/2014
2Mitogen-Activated Protein KinasesIBA
09/2014 - 03/2014
1omega-Chloroacetophenone (Mace)IBA
01/2021
1Histamine Antagonists (Antihistamines)IBA
08/2019
1Type A Botulinum Toxins (Botox)FDA Link
01/2019
1AllergensIBA
01/2018
1Immunoglobulin E (IgE)IBA
01/2018
1Histamine H4 ReceptorsIBA
10/2017
1Messenger RNA (mRNA)IBA
10/2017
1Histamine (Histamine Dihydrochloride)FDA Link
10/2017
1Plant ExtractsIBA
06/2017
1EnzymesIBA
04/2017
1Lamotrigine (Lamictal)FDA LinkGeneric
04/2017
1Pharmaceutical PreparationsIBA
04/2017
1UbiquitinIBA
01/2017
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2017
1AgarIBA
01/2017
1nutlin 3IBA
01/2017
1Vitamin DFDA LinkGeneric
12/2016
1hydroxide ionIBA
12/2016
125-hydroxyvitamin DIBA
12/2016
1Superoxide Dismutase-1IBA
12/2016
1climbazoleIBA
12/2016
1EmollientsIBA
12/2016
1piroctone olamineIBA
12/2016
1Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA
12/2016
1CatalaseIBA
12/2016
1Paclitaxel (Taxol)FDA LinkGeneric
11/2016
1Dihydrotestosterone (Androstanolone)IBA
06/2016
1LipidsIBA
05/2016
1Interleukin-8 (Interleukin 8)IBA
05/2016
1Interleukin-12 Subunit p40IBA
12/2015
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
12/2015
1Interleukin-22 (IL-22)IBA
12/2015
1Indicators and Reagents (Reagents)IBA
10/2015
1Tuberculin (PPD)IBA
07/2015
1epigallocatechin gallate (epigallocatechin-3-gallate)IBA
12/2014
1Antifungal AgentsIBA
12/2014
1Ketoconazole (Nizoral)FDA LinkGeneric
12/2014
1LigninIBA
09/2014
1Anticarcinogenic AgentsIBA
09/2014
1arctiinIBA
09/2014
1Antineoplastic Agents (Antineoplastics)IBA
09/2014
1asiatic acidIBA
09/2014
1TriterpenesIBA
09/2014
1asiaticosideIBA
07/2014
1madecassosideIBA
07/2014
1InterferonsIBA
01/2014
1InterleukinsIBA
01/2014
1Carbon DioxideIBA
11/2013
1Keratins (Keratin)IBA
11/2012
118S Ribosomal RNAIBA
08/2011
128S Ribosomal RNAIBA
08/2011

Therapy/Procedure

3Aftercare (After-Treatment)
03/2016 - 08/2009
2Therapeutics
01/2021 - 03/2009
2Local Anesthesia
06/2018 - 01/2017
1Injections
01/2019
1Intradermal Injections
01/2019
1Lasers (Laser)
11/2013